Back to Articles
‘Barring organised crime, I probably would’ve done anything with him’ - AFR
Australian Financial Review
ENRICHED
Details
- Date Published
- 17 Sept 2026
- Priority Score
- Not scored
- Australian
- Unknown
- Created
- 19 Sept 2026, 12:00 pm
Authors (0)
No authors linked
Description
Jae Lubberink says the at times controversial strategies employed by Eucalyptus under founder Tim Doyle drew him to the business.
Body
Hannah TattersallEditor, AFR Rich ListSep 18, 2026 – 9.00amWhen New-York-listed Hims and Hers splashed $1.6 billion to acquire Eucalyptus – known for medical weight-loss services that prescribe GLP-1s, similar to Ozempic and Mounjaro, and a prescription skincare service – it pushed founder Tim Doyle 10 places up the Young Rich List. It also made millionaires of more than 100 Eucalyptus employees.My lunch guest, Eucalyptus growth manager Jae Lubberink, was not one of them. Not your typical tech start-up guy, Lubberink is a politics, philosophy and economics graduate hired by Doyle last year.Loading...SaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLicense articleRead MoreLunch with the AFRAIObesityHealthMen's healthSkincareOzempicStart-upsCareersHannah TattersallEditor, AFR Rich ListHannah Tattersall is the editor of the AFR Rich List. She was previously a work and careers reporter for The Australian Financial Review. Email Hannah at hannah.tattersall@afr.comFetching latest articles